Clorgyline-induced modification of behavioral sensitization to quinpirole: Effects on local cerebral glucose utilization

Brain Research

Volumn 1160, Issue 1, 2007, Pages 124-133

  Richards, Toni L ^a   Pazdernik, Thomas L ^a   Levant, Beth ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

14C 2 Deoxyglucose; Behavioral sensitization; Clorgyline; D2 D3 dopamine receptor; Obsessive compulsive disorder; Quinpirole

Indexed keywords

CLORGYLINE; DEOXYGLUCOSE; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN CORTEX; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE UTILIZATION; LOCOMOTION; MALE; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAPHE MAGNUS NUCLEUS; RAT; SENSITIZATION;

ANIMALS; ANTIMETABOLITES; BEHAVIOR, ANIMAL; BRAIN MAPPING; CARBON RADIOISOTOPES; CEREBRAL CORTEX; CLORGYLINE; DEOXYGLUCOSE; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; GLUCOSE; MALE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, LONG-EVANS;

RATTUS;

EID: 34447323323     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.05.035     Document Type: Article

References (74)

1. American Psychiatric Association A.P. Diagnostic and Statistical Manual of Mental Disorders (2000), American Psychiatric Press, Washington, DC
2. 2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur. J. Pharmacol. 133 (1987) 137-145
3. Aston-Jones G., and Cohen J.D. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28 (2005) 403-450
4. Aston-Jones G., Shipley M.T., and Grzanna R. The locus coeruleus, A5 and A7 noradrenergic cell groups. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press 183-213
5. Berridge C.W. Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology 31 (2006) 2332-2340
6. Bhattacharyya A.K., and Pradhan S.N. Interactions between motor activity and sterotypy in cocaine-treated rats. Psychopharmacology (Berlin) 63 (1979) 311-312
7. Buck L.B. Smell and taste: the chemical senses. In: Kandel E.R., et al. (Ed). Principles of Neural Science (2000), McGraw-Hill 625-647
8. Carpenter T.L., Pazdernik T.L., and Levant B. Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats. Brain Res. 964 (2003) 295-301
9. Culver K.E., and Szechtman H. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. Eur. J. Pharmacol. 339 (1997) 109-111
10. 2 receptors. Psychopharmacology (Berlin) 167 (2003) 211-218
11. Culver K.E., Rosenfeld J.M., and Szechtman H. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology (Berlin) 151 (2000) 202-210
12. Culver K.E., Rosenfeld J.M., and Szechtman H. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition. Neuropharmacology 43 (2002) 385-393
13. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38 (1995) 95-137
14. 2 agonist quinpirole on locomotion and movements. Eur. J. Pharmacol. 161 (1989) 151-157
15. Einat H., and Szechtman H. Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats. Behav. Brain Res. 54 (1993) 35-41
16. Einat H., and Szechtman H. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole. Physiol. Behav. 57 (1995) 55-59
17. Elliott R., Dolan R.J., and Frith C.D. Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb. Cortex 10 (2000) 308-317
18. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res. Brain Res. Rev. 19 (1994) 223-239
19. Estevez V.S., Ho B.T., and Englert L.F. Metabolism correlates of cocaine-induced stereotypy in rats. Pharmacol. Biochem. Behav. 10 (1979) 267-271
20. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., and Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J. Neurosci. Methods 107 (2001) 107-124
21. Frazer A., and Hensler J. Serotonin. In: Siegel G.J., et al. (Ed). Basic Neurochemistry (1999), Lippincott Williams and Wilkins
22. Friedlander L., and Desrocher M. Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin. Psychol. Rev. 26 (2006) 32-49
23. Gerber III J.C., Choki J., Brunswick D.J., Reivich M., and Frazer A. The effect of antidepressant drugs on regional cerebral glucose utilization in the rat. Brain Res. 269 (1983) 319-325
24. Jaffe J.H. Drug addiction and drug abuse. In: Gilman A.G., et al. (Ed). The Pharmacological Basis of Pharmacology (1993), McGraw-Hill, New York 522-573
25. Jakab R.L., and Leranth C. Septum. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press 405-442
26. Kilbey M.M., and Ellinwood Jr. E.H. Reverse tolerance to stimulant-induced abnormal behavior. Life Sci. 20 (1977) 1063-1075
27. Leith N.J., and Kuczenski R. Chronic amphetamine: tolerance and reverse tolerance reflect different behavioral actions of the drug. Pharmacol. Biochem. Behav. 15 (1981) 399-404
28. Leith N.J., and Kuczenski R. Two dissociable components of behavioral sensitization following repeated amphetamine administration. Psychopharmacology (Berlin) 76 (1982) 310-315
29. 3H]quinpirole binding by monoamine oxidase inhibitors. Life Sci. 71 (2002) 2691-2700
30. Levant B., and Pazdernik T.L. Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats. Brain Res. 1003 (2004) 159-167
31. 2-like dopamine receptors in rat brain. J. Pharmacol. Exp. Ther. 262 (1992) 929-935
32. 3H]quinpirole binding in rat striatal membranes. Eur. J. Pharmacol. 246 (1993) 171-178
33. 3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site. J. Pharmacol. Exp. Ther. 278 (1996) 145-153
34. 3 dopamine receptor-selective doses of 7-OH-DPAT and nafadotride. Brain Res. 812 (1998) 193-199
35. A-deficient mice. Life Sci. 70 (2001) 229-241
36. 2 mediated behavioral responses: a quantitative phenomenological study in rats. Life Sci. 41 (1987) 2135-2145
37. Magos L. Persistence of the effect of amphetamine on stereotyped activity in rats. Eur. J. Pharmacol. 6 (1969) 200-201
38. Marks I.M. Fears, Phobias, and Rituals: Panic, Anxiety, and Their Disorders (1987), Oxford Univ. Press, New York
39. McKay D., Abramowitz J.S., Calamari J.E., Kyrios M., Radomsky A., Sookman D., Taylor S., and Wilhelm S. A critical evaluation of obsessive-compulsive disorder subtypes: symptoms versus mechanisms. Clin. Psychol. Rev. 24 (2004) 283-313
40. Mogilnick E., and Braestrup C. Noradrenergic influence on the stereotyped behavior induced by ampethamine, phenethylamine and apomorphine. J. Pharm. Pharmacol. 28 (1976) 253-255
41. Mueller K., and Nyhan W.L. Clonidine potentiates drug induced self-injurous behavior in rats. Pharmacol. Biochem. Behav. 18 (1983) 891-894
42. National Research Council. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington D.C.
43. Palombo E., Porrino L.J., Crane A.M., Bankiewicz K.S., Kopin I.J., and Sokoloff L. Cerebral metabolic effects of monoamine oxidase inhibition in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine acutely treated monkeys. J. Neurochem. 56 (1991) 1639-1646
44. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, Sydney
45. Piccinelli M., Pini S., Bellantuono C., and Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br. J. Psychiatry 166 (1995) 424-443
46. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev. 25 (1997) 192-216
47. Post R.M., and Contel N.R. Cocaine-induced behavioral sensitization: a model for recurrent manic illness. In: Perris C., et al. (Ed). Biological Psychiatry (1981), Elsevier, Amsterdam 746-749
48. Pradhan S., Roy S.N., and Pradhan S.N. Correlation of behavioral and neurochemical effects of acute administration of cocaine in rats. Life Sci. 22 (1978) 1737-1743
49. Rasmussen S., and Eisen J.L. Phenomenology of OCD: clinical subtypes, heterogeneity and coexistence. In: Zohar J., et al. (Ed). The Psychobiology of Obsessive-Compulsive Disorder (1991), Springer Publishing Company, New York 13-43
50. Richards T.L., Pazdernik T.L., and Levant B. Altered quinpirole-induced local cerebral glucose utilization in anterior cortical regions in rats after sensitization to quinpirole. Brain Res. 1042 (2005) 53-61
51. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396 (1986) 157-198
52. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18 (1993) 247-291
53. Rossi III J. Sensitization induced by kindling and kindling-related phenomena as a model for multiple chemical sensitivity. Toxicology 111 (1996) 87-100
54. Roy S.N., Bhattacharyya A.K., Pradhan S., and Pradhan S.N. Behavioural and neurochemical effects of repeated administration of cocaine in rats. Neuropharmacology 17 (1978) 559-564
55. Saper C.B. Brain stem modulation of sensation, movement, and consciousness. In: Kandel E.R., et al. (Ed). Principles of Neural Science (2000), McGraw-Hill 889-909
56. Segal D.S. Behavioral and neurochemical correlates of repeated d-amphetamine administration. Adv. Biochem. Psychopharmacol. 13 (1975) 247-262
57. Segal D.S., and Mandell A.J. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2 (1974) 249-255
58. Segal D.S., and Schuckit M.S. Animal models of stimulant-induced psychosis. In: Creese I. (Ed). Stimulants: Neurochemical, Behavioral and Clinical Perspectives (1983), Raven Press, New York 131-167
59. Skoog G., and Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch. Gen. Psychiatry 56 (1999) 121-127
60. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28 (1977) 897-916
61. Stein D.J. Obsessive-compulsive disorder. Lancet 360 (2002) 397-405
62. Szechtman H., Talangbayan H., and Eilam D. Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole. Behav. Pharmacol. 4 (1993) 405-410
63. Szechtman H., Sulis W., and Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav. Neurosci. 112 (1998) 1475-1485
64. Szechtman H., Culver K., and Eilam D. Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model. Pol. J. Pharmacol. 51 (1999) 55-61
65. Szechtman H., Eckert M.J., Tse W.S., Boersma J.T., Bonura C.A., McClelland J.Z., Culver K.E., and Eilam D. Compulsive checking behavior of quinpirole-sensitized rats as an animal model of obsessive-compulsive disorder (OCD): form and control. BMC Neurosci. 2 (2001) 4
66. 2 receptor blockade in the dorsal raphe increases quinpirole-induced locomotor excitation. NeuroReport 13 (2002) 563-566
67. 1A receptor stimulation upon cocaine-induced locomotion and sensitization. Neuropsychopharmacology 29 (2004) 1675-1687
68. 2 dopamine receptor. Nature 292 (1981) 463-465
69. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berlin) 151 (2000) 99-120
70. Van Hartesveldt C. Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats. Pharmacol. Biochem. Behav. 58 (1997) 955-960
71. Weissman M.M., Bland R.C., Canino G.J., Greenwald S., Hwu H.G., Lee C.K., Newman S.C., Oakley-Browne M.A., Rubio-Stipec M., Wickramaratne P.J., et al., The Cross National Collaborative Group. The cross national epidemiology of obsessive compulsive disorder. J. Clin. Psychiatry 55 (1994) 5-10 (Suppl.)
72. 2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys. Drug Metab. Dispos. 15 (1987) 107-113
73. White I.M., Doubles L., and Rebec G.V. Cocaine-induced activation of striatal neurons during focused stereotypy in rats. Brain Res. 810 (1998) 146-152
74. Wolf M.E. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol. Interv. 2 (2002) 146-157